GT2-28656-05308
1 vaccination
1 coded response
9 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 773 / TX
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
-
2022-03-18
Survey response — 12 months, dose 1MedDRA: Hypersensitivity, Office visit, Rash, Sinus disorder — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Sinus issues, skin rash, new allergies · Healthcare visit (other): Doctor's appointment, blood test and allergy testMedDRA releases: 2024-11 · check-in free text available
-
2022-03-18
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 1
Symptoms: Sinus issues, skin rash, new allergies
Healthcare visit (other): Doctor's appointment, blood test and allergy test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release